Efzofitimod: a novel anti-inflammatory agent for sarcoidosis.
Saved in:
| Title: | Efzofitimod: a novel anti-inflammatory agent for sarcoidosis. |
|---|---|
| Authors: | Baughman RP; Editor-in-chief, Sarcoidosis, Vasculitis and Diffuse Lung Diseases. BAUGHMRP@UCMAIL.UC.EDU., Niranjan V; vniranjan@atyrpharma.com., Walker G; gwalker@atyrpharma.com., Burkart C; cburkart@atyrpharma.com., Paz S; paz.suzanne@gmail.com., Chong Y; echong@atyrpharma.com., Siefker D; dsiefker@atyrpharma.com., Sun E; esun@atyrpharma.com., Nangle L; lnangle@atyrpharma.com., Forster S; sarah.foerster@ukbonn.de., Muders M; muderslab@gmail.com., Farver C; farverc@ccf.org., Lower E; lowere@ucmail.uc.edu., Shukla S; sshukla@atyrpharma.com., Culver DA; culverd@ccf.org. |
| Source: | Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG [Sarcoidosis Vasc Diffuse Lung Dis] 2023 Mar 28; Vol. 40 (1), pp. e2023011. Date of Electronic Publication: 2023 Mar 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mattioli 1885 Country of Publication: Italy NLM ID: 9610928 Publication Model: Electronic Cited Medium: Internet ISSN: 2532-179X (Electronic) Linking ISSN: 11240490 NLM ISO Abbreviation: Sarcoidosis Vasc Diffuse Lung Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2532-179X |
|---|---|
| DOI: | 10.36141/svdld.v40i1.14396 |
